Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Rookie landlords often rush into LLCs or ignore financing details. This guide explains the real estate mistake that c...
Traders weigh covered calls on mega-cap tech as volatility stays elevated. This article explains how much yield could...
Looking for reliable income and diversification in 2026? These best Vanguard bond picks offer a practical path with c...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...
Policy shifts in California could ripple through the multifamily loan market. This guide explains what to watch, how ...
Waterbridge's 2025 earnings narrative offers insight into growth drivers, cash flow, and capital allocation. This ana...
Two researchers are launching a dedicated effort to bring sustainability back into the AI conversation, promising mea...
Bitcoin sits near key support as a speculative AI-inspired forecast surfaces. The scenario points to a rebound to $80...
A leveraged Treasury ETF illustrates how daily rebalancing can crush long-term returns. TMF turned $10,000 into $1,52...
A staggering, six-sigma-type move in tech stocks grabbed headlines. This article breaks down what happened, why it’s ...
Three monthly dividend ETFs are drawing attention for steady payouts and yields that beat Treasuries. This piece brea...